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ABSTRACT 
This dissertation primarily describes structure-function studies of the prototypical Cys-
loop ligand-gated ion channel, the nicotinic acetylcholine receptors (nAChRs).  
Agonists that bind nAChRs, including acetylcholine, nicotine, and the smoking 
cessation drug varenicline, share one of the longest-known, best-studied pharmacophores, 
consisting of a cationic N and a hydrogen bond acceptor. A major theme of this thesis is 
concerned with defining the nAChR residues that bind the nicotinic pharmacophore.  
Chapters 2 and 3 establish that a hydrogen bond links the pharmacophore’s hydrogen 
bond acceptor to a backbone NH in the protein.  The establishment of this interaction, 
and the disproval of other predicted interactions, represents the completion of the 
nicotinic pharmacophore binding model.  Chapter 4 uses this model to characterize how 
the nAChR differentiates between stereoisomers of an agonist. 
Chapter 5 describes functional studies of a vicinal disulfide that has played a 
pivotal role in a number of pioneering studies of nAChRs.  Despite its historical 
importance, the functional role of this disulfide has not been defined. We identify a 
speculative role for the vicinal disulfide that involves the formation of a functionally 
important network of hydrogen bonds. 
Chapter 6 outlines three strategies for the photochemical cleavage of protein and 
peptide backbones using unnatural amino acids.  One of these strategies is based on a 
selenide-mediated cleavage of a backbone ester moiety.  Model studies establish the 
viability of this chemistry and suggest that it could be a useful tool for protein structure-
function studies. 
  xi 
Chapter 7 concerns preliminary work from a collaboration with laboratories from 
USC and Caltech that is aimed at developing small-molecule treatments for vision loss 
associated with photoreceptor degeneration. The initial goal of this project is to develop a 
photosensitive small molecule that can activate a voltage-gated potassium channel.  
The final chapter discusses work that was done in the Grubbs lab at Caltech in 
which a strategy for preparing N-heterocyclic carbene-containing metal complexes was 
developed. 
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